These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30079814)

  • 1. Social support deficit and depression treatment outcomes in patients with acute coronary syndrome: Findings from the EsDEPACS study.
    Kim JW; Kang HJ; Bae KY; Kim SW; Shin IS; Yoon JS; Hong YJ; Ahn Y; Jeong MH; Kim JM
    Int J Psychiatry Med; 2019 Jan; 54(1):39-52. PubMed ID: 30079814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of depression screening on psychiatric outcomes in patients with acute coronary syndrome: Findings from the K-DEPACS and EsDEPACS studies.
    Kang HJ; Stewart R; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
    Int J Cardiol; 2015; 190():114-21. PubMed ID: 25918060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial.
    Kim JM; Bae KY; Stewart R; Jung BO; Kang HJ; Kim SW; Shin IS; Hong YJ; Kim JH; Shin HY; Kang G; Ahn Y; Kim JK; Jeong MH; Yoon JS
    J Clin Psychiatry; 2015 Jan; 76(1):62-8. PubMed ID: 25375836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants and escitalopram treatment effects on suicidal ideation in patients with acute coronary syndrome: Findings from the K-DEPACS and EsDEPACS studies.
    Kim JM; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Kang H; Yoon JS
    Int J Cardiol; 2016 Sep; 219():225-30. PubMed ID: 27336191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.
    Angermann CE; Gelbrich G; Störk S; Gunold H; Edelmann F; Wachter R; Schunkert H; Graf T; Kindermann I; Haass M; Blankenberg S; Pankuweit S; Prettin C; Gottwik M; Böhm M; Faller H; Deckert J; Ertl G;
    JAMA; 2016 Jun; 315(24):2683-93. PubMed ID: 27367876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
    Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of depressive disorder following acute coronary syndrome: Results from K-DEPACS and EsDEPACS.
    Kang HJ; Stewart R; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
    J Affect Disord; 2015 Aug; 181():1-8. PubMed ID: 25913538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial.
    Kim JM; Stewart R; Lee YS; Lee HJ; Kim MC; Kim JW; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Kim JH; Ahn Y; Jeong MH; Yoon JS
    JAMA; 2018 Jul; 320(4):350-358. PubMed ID: 30043065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF methylation and depressive disorder in acute coronary syndrome: The K-DEPACS and EsDEPACS studies.
    Kim JM; Stewart R; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
    Psychoneuroendocrinology; 2015 Dec; 62():159-65. PubMed ID: 26313133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD).
    Hansen BH; Hanash JA; Rasmussen A; Hansen JF; Birket-Smith M
    Trials; 2009 Apr; 10():20. PubMed ID: 19351383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates and Escitalopram Treatment Effects on Sleep Disturbance in Patients with Acute Coronary Syndrome: K-DEPACS and EsDEPACS.
    Kim JM; Stewart R; Bae KY; Kang HJ; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
    Sleep; 2015 Jul; 38(7):1105-11. PubMed ID: 25581916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences of the Big Five personality traits on the treatment response and longitudinal course of depression in patients with acute coronary syndrome: A randomised controlled trial.
    Kim SY; Stewart R; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
    J Affect Disord; 2016 Oct; 203():38-45. PubMed ID: 27280961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifying effects of depression on the association between BDNF methylation and prognosis of acute coronary syndrome.
    Kim JM; Stewart R; Kim JW; Kang HJ; Lee JY; Kim SY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
    Brain Behav Immun; 2019 Oct; 81():422-429. PubMed ID: 31255678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial.
    Almeida OP; Ford AH; Hirani V; Singh V; vanBockxmeer FM; McCaul K; Flicker L
    Br J Psychiatry; 2014 Dec; 205(6):450-7. PubMed ID: 25257064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
    Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
    Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF val66met polymorphism and depressive disorders in patients with acute coronary syndrome.
    Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
    J Affect Disord; 2016 Apr; 194():1-8. PubMed ID: 26795846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.